{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:40:44Z","timestamp":1792662044371,"version":"4.5.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000313","name":"BSAC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Outpatient parenteral antimicrobial therapy (OPAT) offers safe, effective and patient-centred care for patients with infections requiring IV or complex oral antimicrobial therapy. The UK OPAT Good Practice Recommendations (GPRs) have recently been updated through a systematic literature review, expert consensus and consultation. In this article we outline the key changes in the updated GPRs. There are five new recommendations on (i) self-administration, (ii) OPAT in hard-to-reach groups, (iii) patient education, (iv) developing monitoring protocols for patients on complex oral antimicrobials and on new parenteral administration routes and regimes, and (v) equitable provision of care; and two amended recommendations, on (i) thromboprophylaxis, and (ii) early collaboration with vascular access teams. Overall, the literature demonstrates the increasing confidence of OPAT services in managing complex and comorbid patients, and shows evidence of innovation and collaboration. OPAT has the potential to improve clinical care and antimicrobial stewardship in patients with complex infections in an evolving healthcare landscape.<\/jats:p>","DOI":"10.1093\/jac\/dkag327","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:03:19Z","timestamp":1792659799000},"source":"Crossref","is-referenced-by-count":0,"title":["Updated UK good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT): ensuring quality of care and antimicrobial stewardship in an evolving healthcare landscape"],"prefix":"10.1093","volume":"81","author":[{"given":"Ann L","family":"Noble","sequence":"first","affiliation":[{"name":"NHS Lanarkshire Department of Infectious Diseases, University Hospital Monklands, ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Patel","sequence":"additional","affiliation":[{"name":"Southampton Children\u2019s Hospital Department of Paediatric Immunology and Infectious Diseases, , Southampton ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0625-3535","authenticated-orcid":false,"given":"Mark","family":"Gilchrist","sequence":"additional","affiliation":[{"name":"Imperial College Healthcare NHS Trust\/Imperial College London Department of Infectious Diseases, , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Seaton","sequence":"additional","affiliation":[{"name":"NHS Greater Glasgow and Clyde Department of Infectious Diseases, , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"2026102205031453500_dkag327-B1","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/jac\/dkae177","article-title":"Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review","volume":"79","author":"Wolie","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026102205031453500_dkag327-B2","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae111","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) across the world: a comparative analysis\u2014what lessons can we learn?","volume":"6","author":"Reidy","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2026102205031453500_dkag327-B3","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaf075","article-title":"Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey","volume":"7","author":"Wolie","year":"2025","journal-title":"JAC Antimicrob Resist"},{"key":"2026102205031453500_dkag327-B4","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlz026","article-title":"Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK","volume":"1","author":"Chapman","year":"2019","journal-title":"JAC Antimicrob Resist"},{"key":"2026102205031453500_dkag327-B5","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlag044","article-title":"2026 updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK","volume":"8","author":"Noble","year":"2026","journal-title":"JAC Antimicrob Resist"},{"key":"2026102205031453500_dkag327-B6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijantimicag.2017.03.016","article-title":"Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service","volume":"51","author":"Durojaiye","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2026102205031453500_dkag327-B7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijantimicag.2012.01.016","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years","volume":"39","author":"Barr","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"2026102205031453500_dkag327-B8","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf114","article-title":"OPTIONS-DC: treatment course outcomes following outpatient parenteral antimicrobial therapy RN-led multidisciplinary care conferences for people who use drugs hospitalized with complex infections","volume":"12","author":"Douglass","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2026102205031453500_dkag327-B9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.idc.2022.09.002","article-title":"Outpatient parenteral antibiotic therapy in older adults","volume":"37","author":"Oliver","year":"2023","journal-title":"Infect Dis Clin North Am"},{"key":"2026102205031453500_dkag327-B10","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1136\/archdischild-2022-324143","article-title":"Outpatient parenteral antimicrobial therapy: how young is too young?","volume":"107","author":"Hodgson","year":"2022","journal-title":"Arch Dis Child"},{"key":"2026102205031453500_dkag327-B11","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1093\/jpids\/piy002","article-title":"Outpatient parenteral antimicrobial therapy in young infants","volume":"7","author":"Krah","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2026102205031453500_dkag327-B12","doi-asserted-by":"publisher","first-page":"e1889","DOI":"10.1136\/bmjspcare-2020-002732","article-title":"Antibiotic use towards the end of life: development of good practice recommendations","volume":"14","author":"Seaton","year":"2024","journal-title":"BMJ Support Palliat Care"},{"key":"2026102205031453500_dkag327-B13","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.12968\/bjon.2021.30.2.S4","article-title":"Maximising the opportunity of a self-administration outpatient parenteral antimicrobial therapy pathway","volume":"30","author":"Bodycot","year":"2021","journal-title":"Br J Nurs"},{"key":"2026102205031453500_dkag327-B14","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s15010-025-02549-1","article-title":"Clinical and patient-reported outcomes of self-administered outpatient parenteral antimicrobial treatment (S-OPAT): a scoping review","volume":"53","author":"Maaskant","year":"2025","journal-title":"Infection"},{"key":"2026102205031453500_dkag327-B15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/antibiotics12020330","article-title":"Usefulness of routine laboratory tests for follow up of patients receiving outpatient parenteral antimicrobial therapy run by infectious diseases fellows","volume":"12","author":"Frisby","year":"2023","journal-title":"Antibiotics"},{"key":"2026102205031453500_dkag327-B16","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1177\/1357633X221131842","article-title":"Effectiveness of telemedicine in outpatient parenteral antimicrobial therapy (Tele-OPAT): a systematic review","volume":"30","author":"Durojaiye","year":"2024","journal-title":"J Telemed Telecare"},{"key":"2026102205031453500_dkag327-B17","doi-asserted-by":"publisher","DOI":"10.1177\/20499361231192771","article-title":"Taking the route less travelled: on the way to COpAT","volume":"10","author":"Pertzborn","year":"2023","journal-title":"Ther Adv Infect Dis"},{"key":"2026102205031453500_dkag327-B18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40121-019-0247-0","article-title":"Dalbavancin use in vulnerable patients receiving outpatient parenteral antimicrobial therapy for invasive gram-positive infections","volume":"8","author":"Bork","year":"2019","journal-title":"Infect Dis Ther"},{"key":"2026102205031453500_dkag327-B19","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1093\/jac\/dkaf143","article-title":"Early use of the novel antifungal rezafungin: a case series and literature review","volume":"80","author":"Davidson","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026102205031453500_dkag327-B20","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac117","article-title":"Implementation of IV push antibiotics for outpatients during a national fluid shortage following Hurricane Maria","volume":"9","author":"Yagnik","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2026102205031453500_dkag327-B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.585658","article-title":"Outpatient subcutaneous antimicrobial therapy (OSCAT) as a measure to improve the quality and efficiency of healthcare delivery for patients with serious bacterial infections","volume":"7","author":"Ferry","year":"2020","journal-title":"Front Med"},{"key":"2026102205031453500_dkag327-B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106911","article-title":"Risk of venous thromboembolism in outpatient parenteral antimicrobial therapy (OPAT): a systematic review and meta-analysis","volume":"62","author":"Durojaiye","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"2026102205031453500_dkag327-B23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/cid\/ciz362","article-title":"Quality indicators for appropriate outpatient parenteral antimicrobial therapy in adults: a systematic review and RAND-modified Delphi procedure","volume":"70","author":"Berrevoets","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"Suppl 6","key":"2026102205031453500_dkag327-B24","doi-asserted-by":"publisher","first-page":"vi40","DOI":"10.1093\/jac\/dky117","article-title":"Quality indicators assessing antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure","volume":"73","author":"Mar\u00e9chal","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2026102205031453500_dkag327-B25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1136\/archdischild-2019-317629","article-title":"Being \u2018at-home\u2019 on outpatient parenteral antimicrobial therapy (OPAT): a qualitative study of parents\u2019 experiences of paediatric OPAT","volume":"105","author":"Carter","year":"2020","journal-title":"Arch Dis Child"},{"key":"2026102205031453500_dkag327-B26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12939-020-01261-w","article-title":"Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study","volume":"19","author":"Sumpter","year":"2020","journal-title":"Int J Equity Health"},{"key":"2026102205031453500_dkag327-B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciy867","article-title":"2018 Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy","volume":"68","author":"Norris","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026102205031453500_dkag327-B28","first-page":"123","article-title":"National guidelines on the provision of outpatient parenteral antimicrobial therapy (OPAT)","volume":"113","author":"Sweeney","year":"2020","journal-title":"Ir Med J"},{"key":"2026102205031453500_dkag327-B29","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1007\/s15010-025-02619-4","article-title":"Practice guidelines for outpatient parenteral antimicrobial therapy (OPAT) in Germany","volume":"53","author":"Tometten","year":"2025","journal-title":"Infection"},{"key":"2026102205031453500_dkag327-B30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eimc.2018.03.012","article-title":"Executive summary of outpatient parenteral antimicrobial therapy: guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases and the Spanish Domiciliary Hospitalisation Society","volume":"37","author":"Lopez Cortes","year":"2019","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2026102205031453500_dkag327-B31","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae186","article-title":"A review of antimicrobial stability testing guidance for outpatient parenteral antimicrobial therapy programmes: is it time for global harmonization of testing frameworks?","volume":"6","author":"Naicker","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2026102205031453500_dkag327-B32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/antibiotics14050451","article-title":"Delivery of outpatient parenteral antimicrobial therapy (OPAT) in an ever-changing national health service (UK): benefits, barriers, and opportunities","volume":"14","author":"Durojaiye","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"2026102205031453500_dkag327-B33","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/jac\/dkae183","article-title":"Making a case for outpatient parenteral antimicrobial therapy (OPAT)","volume":"79","author":"Seaton","year":"2024","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/11\/dkag327\/72330260\/dkag327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/11\/dkag327\/72330260\/dkag327.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:03:20Z","timestamp":1792659800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag327\/8974025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag327","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,10,6]]},"article-number":"dkag327"}}